TH1668C3 - A new type of zakhineverian recipe - Google Patents
A new type of zakhineverian recipeInfo
- Publication number
- TH1668C3 TH1668C3 TH303000738U TH0303000738U TH1668C3 TH 1668 C3 TH1668 C3 TH 1668C3 TH 303000738 U TH303000738 U TH 303000738U TH 0303000738 U TH0303000738 U TH 0303000738U TH 1668 C3 TH1668 C3 TH 1668C3
- Authority
- TH
- Thailand
- Prior art keywords
- formulation according
- pharmaceutical formulation
- pharmaceutical
- pvp
- lactose
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 4
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 2
- 208000031886 HIV Infections Diseases 0.000 claims 2
- 208000037357 HIV infectious disease Diseases 0.000 claims 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 2
- 229960001681 croscarmellose sodium Drugs 0.000 claims 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 2
- 239000002270 dispersing agent Substances 0.000 claims 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 2
- 239000000314 lubricant Substances 0.000 claims 2
- 235000019359 magnesium stearate Nutrition 0.000 claims 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 2
- 229920003109 sodium starch glycolate Polymers 0.000 claims 2
- 229940079832 sodium starch glycolate Drugs 0.000 claims 2
- 239000008109 sodium starch glycolate Substances 0.000 claims 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- QACUPNAKIPYZAW-RMQWDSPGSA-N O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O QACUPNAKIPYZAW-RMQWDSPGSA-N 0.000 claims 1
- 229920003081 Povidone K 30 Polymers 0.000 claims 1
- 229920003082 Povidone K 90 Polymers 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 239000008024 pharmaceutical diluent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 235000012222 talc Nutrition 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 239000013583 drug formulation Substances 0.000 abstract 1
- QWAXKHKRTORLEM-UGJKXSETSA-N saquinavir Chemical compound C([C@@H]([C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)C=1N=C2C=CC=CC2=CC=1)C1=CC=CC=C1 QWAXKHKRTORLEM-UGJKXSETSA-N 0.000 abstract 1
- 229960001852 saquinavir Drugs 0.000 abstract 1
Abstract
สูตรผสมทางเภสัชกรรมของยาซาควินาเวียร์ที่มีความแรงของยาเพิ่มมากขึ้น ทำ ให้ผู้ป่วยมีความสะดวกในการรับประทานยามากขึ้นและทำให้ผู้ป่วยรับประทานยาได้สม่ำเสมอ ตามตารางเวลาของขนาดการให้ยาในแต่ละวัน สิทธิบัตรยา The increased potency of the drug formulation of the drug saquinavir makes it more convenient for the patient to take the drug and ensures that the patient takes the drug more consistently. According to the schedule of the daily dosing size
Claims (8)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH1668C3 true TH1668C3 (en) | 2005-02-15 |
| TH1668A3 TH1668A3 (en) | 2005-02-15 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| ATE298324T1 (en) | DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
| CA2363053A1 (en) | Clopidogrel bisulfate tablet formulation | |
| YU58103A (en) | Pharmaceutical dosage forms of epothilones for oral administration | |
| WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| BR0014383A (en) | Controlled release compositions comprising nimesulide | |
| DE60219051D1 (en) | PYRIMIDONE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| IL159217A0 (en) | An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine | |
| RU2006133902A (en) | SOLID PREPARATION FORMS OF OSPEMIFEN | |
| WO2002011694A3 (en) | COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS | |
| TH1668C3 (en) | A new type of zakhineverian recipe | |
| TH1668A3 (en) | A new type of zakhineverian recipe | |
| HRP20090022T3 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING ASCORBINIC ACID FOR THE TREATMENT OF Fungal SUPERINFECTIONS AND Fungal Relapses | |
| HUP0300378A2 (en) | Oxazolidinone tablet formulation and their preparation | |
| TW200517127A (en) | Novel composition | |
| CA2727722A1 (en) | Use of dihydroimidazolones for the treatment of anxiety in dogs | |
| EP1902712A4 (en) | Use of levo-ornidazole for preparing antiparasitic infection drug | |
| AR034142A1 (en) | A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION | |
| TH1705C3 (en) | New pharmaceutical formulas | |
| TH1705A3 (en) | New pharmaceutical formulas | |
| ATE395043T1 (en) | PHARMACEUTICAL EFFORTABLE FORMULATION CONTAINING AMOXYCILLIN AND CLAVULANATE | |
| RU2000115604A (en) | COMPOSITION OF ANTIBACTERIAL MEDICINE | |
| AR030551A1 (en) | USE OF NEFIRACETAM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PROCESSING OF THE RESULTING PHARMACEUTICAL NEURODEGENERATION AND COMPOSITION | |
| ATE381944T1 (en) | INJECTABLE MEDICINAL PRODUCTS CONTAINING AN ANTHRACENEDIONE DERIVATIVE WITH ANTITUMOR ACTIVITY |